Adamantyl derivatives as therapeutic agents

A method for treating cancer in a subject in need of such treatment, the method comprising administering to said subject a therapeutically effective compound, wherein the compound comprises:

• or a pharmaceutically acceptable salt, prodrug, tautomer, regioisomer, stereoisomer, diastereomer, enantiomer or racemate thereof, wherein the cancer is selected from the group consisting of neuroblastoma, breast cancer, cervical cancer, prostate cancer, colon cancer, lung cancer, central nervous system cancer, renal cancer, melanoma, lymphoma, and leukemia.